James R. Mcnab's most recent trade in Titan Pharmaceuticals, Inc. (de) was a trade of 51,021 Common Stock done . Disclosure was reported to the exchange on Jan. 28, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Titan Pharmaceuticals, Inc... | James R. Mcnab | Director | 28 Jan 2022 | 51,021 | 51,021 (0%) | 0% | - | Common Stock | ||
| Titan Pharmaceuticals, Inc... | James R. Mcnab | Director | 05 Jan 2022 | 10,000 | 10,000 | - | - | Option to Purchase Common Stock | ||
| Titan Pharmaceuticals, Inc... | James R. Mcnab | Director | 10 Feb 2021 | 25,000 | 25,000 | - | - | Option to Purchase Common Stock |